neutrophil targeting peptides (Peel Therapeutics)

N/A

Report date: 2025/01/26 17:30:21

Base Information

Drug Nameneutrophil targeting peptides (Peel Therapeutics)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionNeutrophils inhibitors
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Inflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPeel Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPeel Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Inflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A